IDEAS home Printed from https://ideas.repec.org/a/eee/hepoli/v71y2005i2p151-159.html
   My bibliography  Save this article

Evaluating the comparability of different grouping schemes for mortality and morbidity

Author

Listed:
  • Lu, Tsung-Hsueh
  • Jen, Ian
  • Chou, Yiing-Jenq
  • Chang, Hong-Jen

Abstract

No abstract is available for this item.

Suggested Citation

  • Lu, Tsung-Hsueh & Jen, Ian & Chou, Yiing-Jenq & Chang, Hong-Jen, 2005. "Evaluating the comparability of different grouping schemes for mortality and morbidity," Health Policy, Elsevier, vol. 71(2), pages 151-159, February.
    • Handle: RePEc:eee:hepoli:v:71:y:2005:i:2:p:151-159
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0168-8510(04)00182-4
    Download Restriction: Full text for ScienceDirect subscribers only
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Setel, P.W. & Saker, L. & Unwin, N.C. & Hemed, Y. & Whiting, D.R. & Kitange, H., 2004. "Is It Time to Reassess the Categorization of Disease Burdens in Low-Income Countries?," American Journal of Public Health, American Public Health Association, vol. 94(3), pages 384-388.
    2. van Roijen, Leona & Koopmanschap, Marc A. & Rutten, Frans F. H. & van der Maas, Paul J., 1995. "Indirect costs of disease; an international comparison," Health Policy, Elsevier, vol. 33(1), pages 15-29, July.
    3. Shohat, T. & Harari, G. & Green, M.S., 1999. "Mortality from infectious diseases in Israel, 1979-1992, based on revised ICD-9 codes: Implications for international comparisons," American Journal of Public Health, American Public Health Association, vol. 89(12), pages 1855-1857.
    4. Henke, Klaus-Dirk & Behrens, Cornelia S., 1986. "The economic cost of illness in the Federal Republic of Germany in the year 1980," Health Policy, Elsevier, vol. 6(2), pages 119-143.
    5. Henriksson, Freddie & Hjortsberg, Catharina & Rehnberg, Clas, 1999. "Pharmaceutical expenditure in Sweden," Health Policy, Elsevier, vol. 47(2), pages 125-144, May.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Lu, Tsung-Hsueh & Chou, Yiing-Jenq & Liou, Chien-Shian, 2007. "Impact of SARS on healthcare utilization by disease categories: Implications for delivery of healthcare services," Health Policy, Elsevier, vol. 83(2-3), pages 375-381, October.
    2. Lu, Tsung-Hsueh & Huang, Yu-Tung & Chiang, Tung-Liang, 2011. "Using the diamond model to prioritize 30 causes of death by considering both the level of and inequality in mortality," Health Policy, Elsevier, vol. 103(1), pages 63-72.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Susie El Saadany & Douglas Coyle & Antonio Giulivi & Mohammad Afzal, 2005. "Economic burden of hepatitis C in Canada and the potential impact of prevention," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(2), pages 159-165, June.
    2. Hovstadius, Bo & Åstrand, Bengt & Persson, Ulf & Petersson, Göran, 2011. "Acquisition cost of dispensed drugs in individuals with multiple medications--A register-based study in Sweden," Health Policy, Elsevier, vol. 101(2), pages 153-161, July.
    3. Shiell, Alan & Law, Matthew G, 2001. "The cost of hepatitis C and the cost-effectiveness of its prevention," Health Policy, Elsevier, vol. 58(2), pages 121-131, November.
    4. Bergstrom, Gina & Karlberg, Ingvar, 2007. "Decentralized responsibility for costs of outpatient prescription pharmaceuticals in Sweden: Assessment of models for decentralized financing of subsidies from a management perspective," Health Policy, Elsevier, vol. 81(2-3), pages 358-367, May.
    5. Jesús Clemente & Carmen Marcuello & Antonio Montañés, 2008. "Pharmaceutical expenditure, total health‐care expenditure and GDP," Health Economics, John Wiley & Sons, Ltd., vol. 17(10), pages 1187-1206, October.
    6. Johan Polder & Willem Meerding & Luc Bonneux & Paul Maas, 2005. "A cross-national perspective on cost of illness," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(3), pages 223-232, September.
    7. Silke B. Wolfenstetter & Christina M. Wenig, 2010. "Economic Evaluation and Transferability of Physical Activity Programmes in Primary Prevention: A Systematic Review," IJERPH, MDPI, vol. 7(4), pages 1-27, April.
    8. Kildemoes, Helle Wallach & Christiansen, Terkel & Gyrd-Hansen, Dorte & Kristiansen, Ivar Sonbo & Andersen, Morten, 2006. "The impact of population ageing on future Danish drug expenditure," Health Policy, Elsevier, vol. 75(3), pages 298-311, February.
    9. Wiseman, Virginia & Mooney, Gavin, 1998. "SOUNDING BOARD: Burden of illness estimates for priority setting: a debate revisited," Health Policy, Elsevier, vol. 43(3), pages 243-251, March.
    10. Andersson, Karolina & Petzold, Max Gustav & Sonesson, Christian & Lonnroth, Knut & Carlsten, Anders, 2006. "Do policy changes in the pharmaceutical reimbursement schedule affect drug expenditures?: Interrupted time series analysis of cost, volume and cost per volume trends in Sweden 1986-2002," Health Policy, Elsevier, vol. 79(2-3), pages 231-243, December.
    11. Werner B. F. Brouwer & Marc A. Koopmanschap & Frans F. H. Rutten, 1997. "Productivity Costs Measurement Through Quality of Life? A Response to the Recommendation of the Washington Panel," Health Economics, John Wiley & Sons, Ltd., vol. 6(3), pages 253-259, May.
    12. Alexander Bischoff & Tetanye Ekoe & Nicolas Perone & Slim Slama & Louis Loutan, 2009. "Chronic Disease Management in Sub-Saharan Africa: Whose Business Is It?," IJERPH, MDPI, vol. 6(8), pages 1-13, August.
    13. Belaya, V. & Hansen, H. & Pinoir, B., 2013. "Measuring the Costs of Foodborne Diseases: A Review and Classification of the Literature," Proceedings “Schriften der Gesellschaft für Wirtschafts- und Sozialwissenschaften des Landbaues e.V.”, German Association of Agricultural Economists (GEWISOLA), vol. 48, March.
    14. Hovstadius, Bo & Petersson, Göran, 2013. "The impact of increasing polypharmacy on prescribed drug expenditure—A register-based study in Sweden 2005–2009," Health Policy, Elsevier, vol. 109(2), pages 166-174.
    15. Smith, Kirsteen & Wright, Ken, 1996. "Costs of mental illness in Britain," Health Policy, Elsevier, vol. 35(1), pages 61-73, January.
    16. Rockett, Ian R.H. & Samora, Julie B. & Coben, Jeffrey H., 2006. "The black-white suicide paradox: Possible effects of misclassification," Social Science & Medicine, Elsevier, vol. 63(8), pages 2165-2175, October.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:71:y:2005:i:2:p:151-159. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.